Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:http://oc1dean.blogspot.com/2010/11/my-background-story_8.html

Wednesday, January 10, 2018

Importance and Challenges of Moving Stroke Prevention into the Community

What a pile of fucking laziness. Your doctor and stroke hospital have nothing to do but write press releases. No wonder nothing in stroke ever gets solved. Everyone is just sitting on their ass WAITING FOR SOMEONE ELSE TO SOLVE THE PROBLEM. 
No problem, it doesn't affect my salary or payments to the hospital. 
http://circoutcomes.ahajournals.org/content/11/1/e004513?cpetoc= 

Leah L. Zullig, Hayden B. Bosworth

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

See Article by Cheng et al
Stroke is a leading cause of morbidity and mortality in the United States and disproportionally affects minority populations, especially blacks and Hispanics.1 Hence, the importance of the recent study conducted by Cheng et al; they describe the results of a randomized controlled trial testing the efficacy of a multicomponent Chronic Care Model–based intervention among patients receiving care within the Los Angeles, California, public healthcare system2. This is the second largest municipal healthcare system in the United States with a high penetration of minority patients, including many non-English speakers.
The SUSTAIN trial (Systematic Use of Stroke Averting Interventions) tested a complex intervention to address risk factors for stroke. The SUSTAIN intervention included multiple elements—group visits, one-on-one sessions with a care manager to individualize and reinforce the content presented in the group session, clinical visits, and home blood pressure monitoring—compared with an educational control. SUSTAIN’s primary outcome was improvement in systolic blood pressure at 12 months. Secondary outcomes included improvement in cholesterol control, specifically low-density lipoprotein, also at 12 months. Although the study was adequately powered, the primary outcome results were null. Systolic blood pressure decreased in both the intervention and control arms, but the difference in improvement between the groups (−3.6 mm Hg) was not statistically significant.2
To advance the field of stroke prevention and ensure that a balanced view is presented in the literature, publishing both positive and null studies is important. Despite the null findings, SUSTAIN had several noteworthy aspects. The study was conducted in a community healthcare system and enrolled a large proportion of …
View Full Text

No comments:

Post a Comment